FTC would ‘eviscerate’ attorney-client privilege, says Boehringer

01-06-2017

FTC would ‘eviscerate’ attorney-client privilege, says Boehringer

RiverNorthPhotography / iStockphoto.com

The Federal Trade Commission’s (FTC) attempt to obtain Boehringer Ingelheim’s documents relating to a patent dispute settlement would “eviscerate attorney-client privilege”, Boehringer told a US court on Friday, May 26.


FTC, competition, antitrust, patent, patent settlement, Boehringer Ingelheim, Barr Laboratories, Federal Trade Commission

LSIPR